Sign in
Safety and Efficacy of Risuteganib in Intermediate Nonexudative AMD: First Time Results From a Phase 2 Study
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2019
Episode 31- FLUID Study - Dr. Robyn Guymer
Keyvan Koushan, MD, FRCSC
Member Podcasts
Medical Case Conference Raafay Sophie
Raafay Sophie, MD
Category: Inflammatory and Infectious Diseases